PsyRareCare: Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Recruiting
CT.gov ID
NCT05245123
Collaborator
(none)
140
2
9.3
70
7.5

Study Details

Study Description

Brief Summary

Families of children with rare diseases (i.e., not more than 5 out of 10.000 people are affected) are often highly burdened with fears, insecurities and concerns regarding the affected child and his/her siblings. The aim of the present research project is to examine the psychosocial burden of the children with rare solid abdominal tumors and their family in order to draw attention to a possible psychosocial care gap in this population.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The central objective of the cross-sectional study is to show the psychosocial supply gap for families with children and adolescents affected by rare diseases in the field of oncology pediatric surgery. Among the rare diseases that are included are rare solid abdominal tumors. In order to have a comparative sample, additional data of a matched control group are collected. Central standardized psychosocial outcomes will be assessed from the perspectives of the parents and the affected child.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    140 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
    Actual Study Start Date :
    Feb 21, 2022
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Families of rare diseased children

    Clinical study participants are patients who have sought treatment at the University Medical Center Hamburg-Eppendorf and University Medical Centre Mannheim due to the rare disease. Every family receives a comprehensive psychosocial diagnostic in the form of standardized instruments.

    Families in the comparative control group

    Participants in the healthy control sample are matched to the clinical sample in terms of age and gender. Included are families of children aged 0-17 years, who have undergone a surgical procedure in the first 3 years of life that does not cause chronic complaints; such as hernia surgery or testicular relocation.

    Outcome Measures

    Primary Outcome Measures

    1. Quality of Life of the parents (EQ-5D) [1 minutes]

      Quality of Life (QoL) of the parents, assessed from the perspective of the parents by the instrument "European Quality of Life Five Dimension" (EQ-5D; Hinz et al., 2006). The instrument consists of 5 dimensions, which are answered on a three-point scale. Higher scores indicate greater QoL.

    2. Health-related Quality of Life of the parents (SF-12) [4 minutes]

      Health-related Quality of Life (HRQoL) of the parents, assessed from the perspective of the parents by the "Short-Form-12" (SF-12; Morfeld, Kirchberger & Bullinger, 2011). The instrument consists of 12 items. Higher scores indicate greater HRQoL.

    3. Severity of depression (PHQ-9) [2 minutes]

      Severity of depression, will be assessed with the 9-question Patient Health Questionnaire (PHQ-9; Löwe et al., 2015). The instrument consists of 9 items. Higher scores indicate greater depression levels.

    4. Severity of generalized anxiety disorder [1 minutes]

      Generalizied Anxiety Disorder Scale-7 (GAD-7; Spitzer, Kroenke & Löwe, 2006). The instrument consists of 7 items. Higher score indicate greater anxiety levels.

    5. Mental health of the parents (BSI-18) [4 minutes]

      Mental health of the parents, assessed from the perspective of the parents by the "Brief Symptom Inventory-18" (BSI-18; Spitzer et al., 2011). The instrument consists of 18 items, which are answered on a five-point Likert scale (0 to 4). Higher BSI scores indicate greater psychological distress.

    6. Health-related quality of life of the chronically-ill children/adolescents (Peds-QL 4.0) [4 minutes]

      Health-related quality of life of the chronically-ill children/adolescents, assessed from the perspective of the child/adolescent (from 10 years of age) and from the perspective of the parents by the "Pediatric Quality of Life Inventory 4.0" (Peds-QL 4.0; (Varni, Seid, & Kurtin, 2001). Items will be linearly transformed to a scale of 0 to 100, with higher scores indicating better HRQoL.

    7. Psychiatric disorders of the chronically-ill children/adolescents (SDQ) [4 minutes]

      Psychiatric disorders of the chronically-ill children/adolescents assessed perspective of the child/adolescent and from the perspective of the parents by the "Strengths and Difficulties Questionnaire" (SDQ; Klasen, Woerner, Rothenberger, & Goodman, 2003). Items are rated on a three-point Likert scale (0 to 2). Higher scores represent greater psychopathology or greater prosocial behavior.

    Secondary Outcome Measures

    1. Social support of the parents, of the chronically-ill children/adolescents (OSSS) [3 minutes]

      Social support of the parents, of the chronically-ill children/adolescents and of the siblings, assessed from the perspective of the parents, of the chronically-ill children/adolescents and from the sibling, respectively, by the "Oslo Social Support Scale" (OSSS; Dalgard, 2006). The sum score ranges from 3 to 14. The higher the sum score, the stronger the social support

    2. Coping of the parents (CHIP-D) [3 minutes]

      Coping of the parents, assessed from the perspective of the parents by the German version of the "Coping Health Inventory for Parents" (CHIP-D; McCubbin, McCubbin, Cauble & Goldbeck, 2001). Items are rated on a four-point Likert scale (0 to 3). Higher scores represent greater use of the respective coping pattern.

    3. Family relationships, family dynamics and functionality (FB-A) [3 minutes]

      Family relationships, family dynamics and functionality, assessed from the perspective of the parents, of the chronically-ill children/adolescents and from the sibling, respectively by "Familienbögen" (FB-A; Cierpka & Frevert, 1994). Items are rated on a four-point Likert scale (0 to 3)

    4. Familial predispositions (FaBel) [3 minutes]

      familial predispositions assessed from the perspective of the parents by the "Familien-Belastungs-Fragebogen" (FaBel; Ravens-Sieberer, 2001). Items are rated on a four-point Likert scale ranging from 1 (is not right at all) to 4 (is completely right).

    5. Satisfaction with the relationship and parenting relationship of the parents (PFB) [4 minutes]

      Satisfaction with the relationship and parenting relationship of the parents, assessed from the perspective of the parents by the "Partnerschaftsfragebogen" (PFB; Hahlweg, 2016).

    6. Parent-child communication (PACS) [4 minutes]

      Parent-child communication was assessed from the perspective of the child/adolescent and from the perspective of the parents by the "Parent-Adolescent Communication Scale" (PACS; Barnes & Olsen, 1982). Items are rated on a five-point Likert scale.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 17 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria (families of rare disease):
    • Family with at least one child between 0 and 17 years with rare solid abdominal tumors.

    • Consent to participate in the study.

    • Sufficient knowledge of the German language of parents and children.

    Exclusion Criteria (families of rare disease):
    • Severe acute physical, mental and/or cognitive impairment of the child, so that the questionnaire survey does not appear possible and/or unreasonable at this stage.
    Inclusion Criteria (control group):
    • Family with at least one child between 0 and 17 years who have undergone a surgical procedure in the first 3 years of life that does not cause chronic complaints

    • Consent to participate in the study.

    • Sufficient knowledge of the German language of parents and children.

    Exclusion Criteria (control group):
    • Families of children with a congenital or chronic disease.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Medical Center Mannheim Mannheim Baden-Württemberg Germany 68167
    2 University Medical Center Hamburg-Eppendorf Hamburg Germany 20251

    Sponsors and Collaborators

    • Universitätsklinikum Hamburg-Eppendorf

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Johannes Boettcher, Principal Investigator, Universitätsklinikum Hamburg-Eppendorf
    ClinicalTrials.gov Identifier:
    NCT05245123
    Other Study ID Numbers:
    • 2021-100605-BO-ff
    First Posted:
    Feb 17, 2022
    Last Update Posted:
    Mar 8, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Johannes Boettcher, Principal Investigator, Universitätsklinikum Hamburg-Eppendorf
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 8, 2022